+Advanced Search
Home > Archive>Volume 30, Issue 4, 2020 >121-130. DOI:10. 3969 / j.issn.1671-7856. 2020. 04. 019
PDF HTML XML Export Cite reminder
Progress in lipid-lowering model research
Author:
Affiliation:

Pharmacy College, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization of Chinese Herbal Medicine, Ministry of Education, State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources Co-Founded by Sichuan Province and Ministry of Science and Technology, Chengdu 611137, China

Clc Number:

R-33

  • Article
    • | |
  • Metrics
    • | | | | |
  • Comments
    Abstract:

    Hyperlipidemia is a type of disease involving lipid metabolism disorders. It is also the leading cause of cardiovascular and cerebrovascular diseases, such as coronary heart disease, cerebral infarction and atherosclerosis, which have become one of the most harmful chronic diseases to human health in the word. At present, the development of new, high-efficiency and low-toxicity target, lipid-lowering, hypolipidemic, traditional Chinese medicines is essential for improving hyperlipidemia and its secondary cardiovascular and cerebrovascular diseases. However, because of the complexity and compatibility of traditional Chinese medicine ingredients, it is difficult to conduct in-depth research on the effective components of the therapeutic effect and the specific lipid-lowering mechanism by relying on a single lipid-lowering model. Therefore, the establishment of an ideal high-fat model is a key factor in screening lipid-lowering Chinese medicines and studying the pathogenesis of hyperlipidemia. In this paper, several of the most commonly used lipid-lowering models were reviewed from three aspects: cell models, mammalian models and zebrafish models, and the common modeling method of various models and their respective advantages and disadvantages were summarized. As a result , this work provides references and an experimental basis for selecting reproducible hyperlipidemia models for hyperlipidemia mechanism research and screening of effective lipid-lowering traditional Chinese medicines.

    Reference
    Related
    Cited by
Get Citation

Copy
Share
Article Metrics
  • Abstract:3105
  • PDF: 3168
  • HTML: 0
  • Cited by: 0
History
  • Received:July 24,2019
  • Online: May 14,2020
Article QR Code
You are the first3043879 Visitors
® 2025 All Rights Reserved
Address：5 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China Postcode： Phone：86-10-67779337 E-mail:bjb@cnilas.org
Supported by:Beijing E-Tiller Technology Development Co., Ltd.